News | February 18, 2021
Granules India announces approval of Potassium Chloride ER Capsules
Granules now has a total of 37 ANDA approvals from US FDA (36 Final approvals and 1 tentative approvals).
Granules now has a total of 37 ANDA approvals from US FDA (36 Final approvals and 1 tentative approvals).
India business grew 11.8% YoY vs mid-single digit industry growth.
The jump in profit is due to the better performance of the API business.
The company continued to maintain clear FDA status across its plants and has received 12 ANDA approvals during 9MFY21
The pandemic has provided tailwinds in terms of access to rural healthcare and India’s emergence as a vaccine powerhouse
The medical device Sector in India suffers from a considerable cost of manufacturing disability.
Be One is a 100% Ayurvedic health and wellness supplement.
The Department has been working continuously to ensure a stable long-term policy environment and reduce the compliance burden on the Industry.
The partnership is a significant step in delivering advanced cancer therapies to patients.
The company has concluded our acquisition of Richcore Lifesciences on 20th Jan 2021.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)